KIM LLC’s Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share IBER.WS Stock Holding History

KIM LLC’s Portfolio IBER.WS Stock Details IBER.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-200,000	Closed	-$2K	–	657
2022 Q4	$2K	Hold	200,000	–	–	﹤0.01%	593
2022 Q3	$20K	Hold	200,000	–	–	﹤0.01%	543
2022 Q2	$16K	Buy	+200,000	New	+$34.5K	﹤0.01%	651

Other funds holding IBER.WS

LCM

Lynwood Capital Management Toronto, Ontario, Canada $16.9M AUM 19.31% 1-Year Est. Return

KIM LLC's IBER.WS Position: Q1 2023 in Review

KIM LLC sold out of Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share (IBER.WS) in Q1 2023, closing a stake of 200,000 shares — an estimated $2K sold.

KIM LLC first reported a position in IBER.WS in Q2 2022 and held it in 3 quarters. The position peaked at $20K in Q3 2022. 1 fund tracked by Wall St. Rank holds IBER.WS as of Q1 2023.

KIM LLC reported no remaining Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position as of Q1 2023 after selling out during the quarter.
KIM LLC sold 200,000 Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share shares in Q1 2023, an estimated $2K.
KIM LLC first reported a position in Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in Q2 2022 and held it in 3 quarters.
KIM LLC's Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position peaked at $20K in Q3 2022.
1 fund tracked by Wall St. Rank held Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share as of Q1 2023.

Based on KIM LLC's 13F filing for Q1 2023, filed 11 May 2023.